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Maturation of the 40S ribosomal subunit precursors in mammals mobilizes several non-ribosomal proteins, including the
atypical protein kinase RioK2. Here, we have investigated the involvement of another member of the RIO kinase family,
RioK3, in human ribosome biogenesis. RioK3 is a cytoplasmic protein that does not seem to shuttle between nucleus and
cytoplasm via a Crm1-dependent mechanism as does RioK2 and which sediments with cytoplasmic 40S ribosomal
particles in a sucrose gradient. When the small ribosomal subunit biogenesis is impaired by depletion of either rpS15,
rpS19 or RioK2, a concomitant decrease in the amount of RioK3 is observed. Surprisingly, we observed a dramatic and
specific increase in the levels of RioK3 when the biogenesis of the large ribosomal subunit is impaired. A fraction of RioK3
is associated with the non ribosomal pre-40S particle components hLtv1 and hEnp1 as well as with the 18S-E pre-rRNA
indicating that it belongs to a bona fide cytoplasmic pre-40S particle. Finally, RioK3 depletion leads to an increase in the
levels of the 21S rRNA precursor in the 18S rRNA production pathway. Altogether, our results strongly suggest that RioK3
is a novel cytoplasmic component of pre-40S pre-ribosomal particle(s) in human cells, required for normal processing of
the 21S pre-rRNA.
Introduction
While the nascent pre-rRNA is being transcribed by RNA
polymerase I in the nucleolus, it associates with a subset of
snoRNPs, ribosomal and non-ribosomal proteins, resulting in the
assembly of so-called pre-ribosomal particles.
1-6 Either during
transcription or post-transcriptionally, the newly transcribed pre-
rRNA undergoes endonucleolytic cleavages that release the
precursors to the large and small ribosomal subunits, the pre-
60S and pre-40S particles respectively.
7 These precursors will then
undergo separate and largely independent maturation pathways.
In the course of their maturation, pre-ribosomal particles transit
from the nucleolus to the cytoplasm via the nucleoplasm and
nuclear pores
4,8,9. Both types of precursor particles undergo final
maturation steps in the cytoplasm to acquire translational
competence (for reviews see refs. 8 and 10).
More than a hundred of non-ribosomal proteins dynamically
associate with and dissociate from pre-ribosomal particles at
various stages of their maturation.
2,10,11 Among these non-
ribosomal proteins feature endo- and exoribonucleases, nucleotide
modifying enzymes, RNA helicases, NTPases, kinases, RNA-
binding proteins etc… However, many non-ribosomal proteins
fail to display any easily recognizable motif. Most of these factors
are essential for viability and ribosome synthesis in yeast, yet their
precise molecular functions remain elusive, with the notable
exception of nucleases involved in pre-rRNA processing. These
non-ribosomal proteins may promote ribosomal protein assembly,
pre-rRNA structural rearrangements, pre-rRNA spacer digestion,
pre-ribosomal particle transport or participate in quality control
of ribosome biogenesis.
Maturation of pre-40S pre-ribosomal particles may prove less
complex than that of pre-60S particles, as far fewer non-ribosomal
proteins associate with pre-40S particles, at least in yeast.
12 The
major non-ribosomal constituents of yeast pre-40S particles are
the kinases Hrr25p,
13 Rio1p and Rio2p,
14,15 the 18S rRNA
methyl-transferase Dim1p,
16,17 the Nob1p endonuclease,
18-20 the
putative RNA-binding protein Dim2p,
21,22 the heat repeat protein
Rrp12p
23 and the Enp1p,
24,25 Ltv1p
3,26 and Tsr1p
27 proteins. In
addition, pre-40S particles transiently interact with the Fap7p
NTPase
28 and with the DEAH helicase Prp43p in complex
with its G-patch-containing protein partner Pfa1p.
20,29 Dim1p,
Dim2p, Enp1p, Hrr25p, Nob1p, Rrp12p and Tsr1p probably
associate early with nucleolar 90S pre-ribosomal particles,
3,30 while
Ltv1p, Rio1p and Rio2p join later nuclear pre-40S particles
generated following pre-RNA cleavage at site A2 in internal
transcribed spacer 1.
31,32 The molecular functions of some of these
factors are starting being defined. Nob1p is the endonuclease
that converts yeast 20S pre-rRNA into 18S rRNA in the cyto-
plasm,
20,33,34 following a conformational rearrangement of cyto-
plasmic pre-40S particles requiring Prp43p, Pfa1p and Ltv1p. The
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Hrr25p kinase is responsible for the nuclear phosphorylation of
ribosomal protein Rps3p and its direct partner Enp1p, which
weakens the association of Rps3p and Enp1p with the pre-40S
particles, a likely prerequisite for passage of these particles through
the nuclear pore.
30 The two other kinases present in yeast pre-40S
particles, the Rio1p and Rio2p kinases, are each required for
the cytoplasmic conversion of 20S pre-rRNA into 18S rRNA,
demonstrating that they do not play redundant functions in
ribosome biogenesis.
14,15 The composition of human pre-40S
particles is starting being defined. So far, it appears that human
and yeast pre-40S particles share several highly conserved non-
ribosomal protein components, including hEnp1/bystin, hLtv1
and RioK2.
35 However, the pre-40S maturation pathway is more
complex in human than in yeast cells: elimination of the ITS1-
fragment within the yeast pre-40S particles requires a single
cytoplasmic cleavage step at the 3' end of the 18S rRNA, while
one detects 3 intermediates in pre-40S particles in human cells,
namely the 21S
36 and 21S-C
37 pre-rRNAs that are nuclear, and
the cytoplamic 18S-E pre-rRNA.
38
The yeast Rio1p and Rio2p and the human RioK2 proteins
are members of the RIO (right open reading frame) family of
atypical protein kinases (aPK).
39 This family is characterized by
the presence of the RIO kinase domain, a kinase fold structurally
homologous to eukaryotic protein kinase (ePK) domains but
lacking the loops known to be important for substrate binding
in the canonical kinases, as well as the so-called “activation loop,”
the phosphorylation of which modulates kinase activity.
40-42
Another distinguishing feature of the RIO kinase domain is the
presence of a “flexible loop” that may interfere with nucleotide
binding.
43 The Rio1 and Rio2 proteins are conserved from
archaea to mammals. In contrast, some eubacterial species contain
a single representative of the RIO protein family, displaying
similarities to Rio1 and Rio2 proteins at its N- and C-terminus,
respectively, suggesting that a common ancestor of the two
proteins may have existed.
44,45 A third type of RIO protein named
Rio3 was described, which is more similar to Rio1.
39 Genes
encoding Rio3 proteins have only been found in multicellular
eukaryotes thus far. In humans, the three RIO kinases have been
termed RioK1, RioK2 and RioK3. RioK2 has been shown to
be required for the conversion of the 18S-E pre-rRNA precursor
into mature 18S rRNA, confirming the requirement for Rio2
proteins in the last step of mature 18S rRNA production,
38 and
recycling of several non-ribosomal factors.
35 In the present study,
we have investigated the role of the human RioK3 protein in
ribosome biogenesis. Our results strongly suggest that RioK3 is
a component of cytoplasmic pre-40S particles and show that
its depletion leads to an accumulation of the 21S pre-rRNA, a
precursor to 18S rRNA. Hence human 40S ribosomal subunit
biogenesis mobilizes an additional member of the RIO kinase
family compared with yeast.
Results
Human RioK3 is cytoplasmic and sediments with 40S ribosomal
particles. The RioK3 protein is highly conserved among multi-
cellular eukaryotes (Fig.1A). The RioK3 central domain is a
canonical RIO domain, based on the founding member of the
family, yeast Rio1p, containing an ATP-binding site, a flexible
loop, a hinge, a catalytic site and a metal- binding loop.
46 The
RioK3 primary structure also features a conserved N-terminal
domain (1–255) predicted to be highly helical, but displaying
no sequence homology to any known protein (Fig.1B). At
the beginning of our study, the RioK3 protein was totally
uncharacterized experimentally. We thus first determined its sub-
cellular localization. HeLa cells expressing a cDNA encoding this
protein fused to the enhanced green fluorescent protein (EGFP)
displayed a fluorescent signal restricted to the cytoplasm when
observed by confocal microscopy (Fig.1C). Consistent with
this observation, after cellular fractionation, endogenous RioK3
detected by western blot analysis was only found in the cyto-
plasmic fraction (Fig.1D). To assess whether RioK3 enters the
nucleus and is rapidly exported back in the cytoplasm by a
Crm1-dependent mechanism, cells expressing EGFP-RioK3 were
treated for 2 h with Leptomycin B (LMB), a drug inhibiting
the exportin Crm1.
47 Most of EGFP-RioK3 remained in the
cytoplasm (Fig.1E), when under similar conditions, EGFP-
RioK2 became concentrated in the nucleus (Fig.1E), as pre-
viously described for both yeast Rio2p and human RioK2.
15,38
These results suggest that, contrary to these latter proteins,
RioK3 is not actively exported from the nucleus by a Crm1-
dependent mechanism, at least in the HeLa cells we are
using. Moreover, should RioK3 be actively exported from the
nucleus, this probably does not occur by “piggybacking” on pre-
ribosomal particles as inhibition of ribosome biogenesis by
actinomycin D did not perturb EGFP-RioK3 localization (data
not shown).
Figure1 (See opposite page). RioK3 conservation, sub-cellular localization and sedimentation on density gradient. (A) Alignment of RioK3 from diverse
organisms (X. laevis, E. caballus, M. musculus, B. taurus, M. fascicularis and H. sapiens) showing the high degree of conservation of the protein. The conserved
N-ter domain is framedinblue. The RIO kinase domain contains theATP-bindingloop, theflexibleloop, the hinge region, and the catalytic and metal-binding
loops as determined from the structure of the A. fulgidus Rio2 protein.
55,56 (B) Schematic diagram of the domain organization of RioK3 showing sequence
signatures within the rectangle representing the RIO domain. The well conserved N and C domains have no sequence homologs in any known protein.
(C) HeLa cells expressing EGFP-RioK3 and EGFP observed by laser-scanning confocal microscopy. (D) western blot analysis of HeLa cell cytoplasmic and
nuclear fractions performed with an anti-RioK3 antibody showing that RioK3 is a cytoplasmic protein. As a control, the component of the box HACA snoRNPs
dyskerin is detected mainly in the nuclear fraction. (E) 48 h after transfection with the EGFP-RioK3 (left) or EGFP-RioK2 (right) expression vector, cells were
treated with 10 nM LMB for 2 h and then observed by laser-scanning confocal microscopy. EGFP-RioK3 localization is not affected when Crm1 is inhibited by
LMB,incontrastto EGFP-RioK2which isclearlyretained in the nucleus.(F) Centrifugationof a HeLacellcytoplasmicextractona 15–50% sucrose gradientand
Western/Northern blot analyses of the gradient fractions. Fractions were analyzed by western blot with antibodies against RioK3, RioK2 and Rps19. The 18S
and28S rRNAsweredetectedby ethidiumbromidestainingandthe18S-Especieswasrevealedbynorthernblottingwitha59-ITS1probe.Thisanalysisshows
that the totality of RioK3 co-sediments with (pre)-40S particles, as does RioK2.
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We next assessed the sedimentation profile of RioK3 on a
sucrose density gradient. A cytoplasmic fraction prepared in the
presence of cycloheximide was separated on a 15–50% (w/v)
sucrose density gradient (Fig.1F). The distribution of free 40S
and 60S ribosomal subunits and 80S ribosomes was assessed by
monitoring absorbance at 254 nm, and by detection of the 18S
and 28S rRNAs in each fraction (note that on this type of
gradient, polysomes are sedimenting at the bottom of the tube
and are absent from the profile). Fractions containing pre-40S
particles were identified by the presence of the 18S-E pre-rRNA
detected by northern-blotting with a 5'-ITS1 probe. The
sedimentation on sucrose gradients of RioK3 and RioK2 as
control was analyzed by the western blotting procedure using
specific antibodies. The totality of RioK3 sediments with free
40S/pre-40S ribosomal subunits, as does RioK2. Altogether, these
results suggest that RioK3 could be a component of cytoplasmic
pre-40S particles or of the cytoplasmic 40S ribosomal subunit.
RioK3 levels are reduced when the small ribosomal subunit
(SSU) biogenesis is impaired. In order to determine whether
RioK3 belongs to some pre-40S particle(s), we analyzed the effect
of SSU biogenesis impairment on the levels of RioK3. As shown
in Figure2A, depletion of the small subunit ribosomal proteins
Rps15 or Rps19 using appropriate siRNAs resulted, as expected,
in a significant drop in the levels of free 40S particles, with a
concomitant increase in free 60S particles. Under these condi-
tions, RioK3 sedimentation profile was unchanged: it was still
present in the gradient fractions containing the remaining free
40S particles but its amount was decreased by approximately 50%
or 30% in the case of Rps15 or Rps19 depletion, respectively
(Fig.2A-C). Likewise, depletion of Rps15 or Rps19 significantly
decreased the levels of RioK2 (Fig.2B). Moreover, knockdown of
RioK2 expression by siRNA treatment also resulted in a signifi-
cant drop in 40S particle levels correlated with an approximate
30% decrease in RioK3 levels (Fig.2A-C). Together, these results
indicate that the amount of RioK3 vary with the levels of free 40S
particles or pre-40S particles, as is the case for RioK2, suggesting
that RioK3 may be a component of pre-40S particles or 40S
subunits.
RioK3 levels are specifically increased when large ribosomal
subunit (LSU) biogenesis is impaired. We then assessed the
consequence of inhibition of LSU biogenesis on RioK3 levels.
Strikingly, when LSU biogenesis was impaired in HeLa cells by
depletion of either Rpl11 or Rpl5 using siRNAs, we observed a
dramatic and specific increase (approximately 10-fold) in RioK3
levels (Fig.2D and F) as compared with scramble siRNA-treated
cells. In extracts from siRpl5-treated cells, the increase in RioK3
levels was lower (~5 fold increase) than that observed in siRpl11-
treated cells (Fig.2F). We also detected a significant and specific
increase (~5-fold) in RioK3 levels in U2OS cells transfected with
either Rpl11 or Rpl5 siRNAs (data not shown). Analysis of the
ribosomal profile on sucrose gradient after Rpl11 depletion
confirmed that the amount of free 60S particles was significantly
decreased, with a concomitant increase in free 40S particles as
expected for the depletion of a LSU ribosomal protein (Fig.2E)a s
compared with the profile obtained with extracts from scramble
siRNA-treated cells (Fig.2A). All RioK3 was found in the 40S
fractions of the gradient, suggesting that even when the amount
of RioK3 is vastly increased, most RioK3 proteins remain asso-
ciated with the pre-40S particles and/or 40S ribosomal subunits.
We then checked whether the levels of other pre-40S factors were
also increased when LSU biogenesis was impaired. As previously
described for RioK3, the amounts of RioK2, hLtv1 and hEnp1
were determined by western blot analysis using cellular extracts
from scramble, siRpl11 or siRpl5-treated cells (Fig.G,H and I).
In extracts from siRpl11-treated cells, the levels of RioK2, hLtv1
and hEnp1 remained fairly constant or show a slight increase (1.1-
to 2.4-fold, Fig.2G, H, I). Altogether, these results confirm the
correlation between the levels of RioK3 and those of free 40S/pre-
40S particles.
RioK3 is associated with pre-40S particle components hLtv1,
hEnp1 and 18S-E. We next sought to directly assess whether
RioK3 is associated with pre-40S particle components by
immunoprecipitation. We failed to efficiently precipitate endo-
genous RioK3 using the commercially available anti-RioK3
antibody (not shown). Therefore, we decided to check whether
RioK3 is co-precipitated with protein components of human pre-
40S particles. We made use of good antibodies against hEnp1/
bystin and hLtv1, known components of human pre-40S
particles.
35,37 A HeLa cytoplasmic extract was fractionated on a
preparative sucrose gradient and the 40S fractions containing
Figure2 (See opposite page). Impact of Rps15, Rps19, RioK2, Rpl5 or Rpl11 depletion on ribosome biogenesis and accumulation of RioK3 and other
components of pre-40S particles. (A) Cytoplasmic extracts, prepared from cycloheximide-treated cells 48h after transfection with a scramble siRNA or
a siRNA targeting Rps15, Rps19, RioK2 or RioK3, were subjected to ultracentrifugation in 15–50% sucrose gradients. Identical amounts of each fraction
were analyzed by western using an anti-RioK3 antibody. Detection of the chemiluminescence by autoradiography was performed for the same duration
in all cases. (B) Accumulation of RioK3 and RioK2 in siRNA-treated cells described in (A). Total cellular extracts from these cells were analyzed by western
using antibodies against RioK3, RioK2 and actin. (C) Quantifications of the amounts of RioK3 performed using a Bioimager after western blot analysis.
The quantity of each protein was normalized to that of actin and expressed as percentages, the quantity in cells treated with scramble siRNAs being set
at 100%. Values presented are the means (+/2SEM) of 5 independent experiments. Pair-wise statistical analysis was performed with Student’s t-test.
*p , 0.05; **p , 0.01; ***p , 0.001. (D) Total cellular extracts prepared 48 h after transfection with either scramble, rpL11 (10 and 50 nM) or rpL5 (10 and
50 nM) siRNAs were analyzed by the Western procedure with antibodies specific for RioK3, RioK2, hLtv1, hEnp1 and actin. A longer exposure (*) is shown
in the case of RioK3. (E) Sucrose gradient sedimentation profile of ribosomal particles from a cytoplasmic extract produced from siRpl11-treated cells.
Fractions were analyzed by the Western procedure with an anti-RioK3 antibody. Blots were exposed for the same time in (D) and (E). (F-I) Quantifications
of the amounts of RioK3 (F), RioK2 (G), hLtv1 (H), hEnp1 (I) performed using a Bioimager after western blot analysis. As in (C), the quantity of each protein
was normalized to that of actin and expressed as percentages, the quantity in cells treated with scramble siRNAs being set at 100%. Values presented
are the means of 3 independent experiments (+/2SEM). Pair-wise statistical analysis was performed with Student’s t-test. *p , 0.05; **p , 0.01;
***p , 0.001.
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hLtv1, hEnp1, RioK2 and RioK3 were pooled (Fig.3A) and
subjected to immunoprecipitation with anti-hLtv1 or anti-hEnp1
antibodies. The anti-hLtv1 antibodies immunoprecipitated hLtv1
very efficiently (Fig.3B). Use of these antibodies also led to the
very efficient co-precipitation of hEnp1 and RioK2 (approxi-
mately ~70–95% recovery), while RioK3 was also co-precipitated,
but to a lesser extent (approximately ~30% recovery, Fig.3B and
C). Similarly, the anti-hEnp1 antibodies immunoprecipitated
efficiently hEnp1 together with hLtv1, RioK2 and to a far lesser
extent RioK3 (Fig.3B and C). Northern blot analysis of the
RNAs co-precipitated with anti-hLtv1 or anti-hEnp1 antibodies
showed that the 18S-E pre-rRNA was recovered with a very
high yield (respectively 90% and 56% of input) (Fig.3D).
Hybridization with a probe complementary to 18S rRNA (and
necessarily to 18S-E pre-rRNA also) shows that 35% and 20% of
the combined 18S rRNA + 18S-E pre-rRNA input species are
precipitated with hLtv1 and hEnp1, respectively. These results
strongly suggest that RioK3 is a component of a particle con-
taining also two bona fide components of pre-40S particles and
18S-E pre-rRNA.
To confirm that RioK3 itself is associated with 18S-E pre-
rRNA, we performed a direct immunoprecipitation of a trans-
iently expressed HA-tagged RioK3. A cytoplasmic extract from
HeLa cells transfected with plasmid E46-HA-RioK3 allowing the
transient expression of HA-RioK3 (that co-sediments with
endogenous RioK3 on a sucrose gradient, data not shown) was
subjected to ultracentrifugation in a sucrose gradient. The
fractions containing pre-40S and 40S particles, checked for their
content in HA-RioK3, were pooled and used in immunopreci-
pitation experiments performed with an anti-HA affinity matrix
(Fig.4A). The co-precipitated RNAs were analyzed by real time
RT-q-PCR (Fig.4B) because the amount of RNA co-precipitated
with the transiently expressed tagged-protein is too low to allow
its analysis by Northern-blot. 18S-E pre-rRNA and 18S rRNA +
18S-E pre-rRNA were significantly amplified from IP samples
obtained using the anti-HA matrix (BHA lanes) as compared
with control samples from mock precipitation experiments
omitting anti-HA antibodies (B0 lanes). In contrast, 28S rRNA
and the Gapdh mRNA were not amplified from these samples
(as expected since 40S fractions were used as starting material
for these experiments). Comparison of the amplification levels
obtained for 18S-E pre-rRNA and 18S rRNA + 18S-E pre-rRNA
from the 40S Input fraction and from the HA-IP sample shows
that the ratio 18S-E/(18S + 18S-E) is much more elevated in the
IP sample: the ratio 18S-E/(18S + 18S-E) of ~0.25 observed in
the Input increases to ~1.45 in the BHA fraction, corresponding
to a more than 5x enrichment in 18S-E relative to 18S in the
HA-RioK3 IP sample. These data strongly suggest that RioK3 is
present in pre-40S particles containing the 18S-E pre-rRNA.
RioK3 depletion leads to a specific increase in 21S pre-rRNA
levels. Requirement of RioK3 for ribosome synthesis was
assessed by knocking-down expression of this protein with a
Figure3. Immunoprecipitation of pre-40S particles. (A) A HeLa cell cytoplasmic extract was subjected to ultracentrifugation in a preparative sucrose
gradient. Gradient fractions were analyzed by the western blot procedure with antibodies against hLtv1, hEnp1, RioK3 and RioK2. Fractions 17 and 18,
containing the bulk of these proteins and presumably pre-40S particles, were pooled. (B) western blot analysis of proteins precipitated from these
fractions using IgG beads pre-incubated with non-immune (control), anti-hLtv1 or anti-hEnp1 sera. Proteins were extracted from the bead pellets
(75% of the IP samples loaded) or from a volume of gradient fractions equivalent to that used as input (Input) and analyzed by western blot
with antibodies against hLtv1, hEnp1, RioK3 and RioK2. (C) Percentage of protein recovery following immunoprecipitation. (D) northern blot analysis
of the co-precipitated RNAs. RNAs loaded were extracted from 30 ml of the input 40S fraction (Input) or from the bead pellets (IP) obtained
following immunoprecipitation performed with the same fraction volume and analyzed by the northern procedure using the 59-ITS1 probe to detect
18S-E pre-rRNA, and the 18S probe to detect 18S rRNA + 18S-E pre-rRNA (see Table S1).
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siRNA treatment. RioK3 depletion 48 h after siRNA treatment
is efficient (the protein level measured by western-Blot was
decreased by ~90% as shown in Fig.2B), with no clear modifi-
cation in the ribosome profile (Fig.2A) as compared with the
profile obtained with an extract from scramble siRNA-treated cells
(Fig.2A). We did not observe any modification in the amount
of RioK2 (Fig.2B) when RioK3 was depleted, while on the
contrary, RioK2 depletion clearly affected RioK3 level (Fig.2B)
as well as the one of free 40S particles (Fig.2A). Since subtle
effects of RioK3 depletion on pre-rRNA maturation cannot be
excluded, we analyzed total cellular RNAs 48 h post-transfection
with RioK3 siRNAs or either scramble, Rps15, Rps19 or Rpl11
siRNAs (Fig.5A). Mature 18S and 28S rRNA amounts were
measured after agarose gel electrophoresis and ethidium bromide
staining and amounts of 18S rRNA precursors were determined
by northern blot analysis with a 5'ITS1 probe (Fig.5B and
Fig. S1 for the pre-rRNA processing scheme). The
18S/28S molar ratio was not found to change
significantly when RioK3 was depleted, compared
with Rps15, Rps19 or Rpl11 depletions. The
most important effect we detected is the increased
accumulation of the 21S intermediate (Fig.5A,B).
Altogether, these results indicate that the absence of
RioK3 leads to a subtle disturbance of the pre-rRNA
processing pathway leading to 18S rRNA synthesis.
Discussion
The data presented here indicate that in HeLa cells,
RioK3, the protein of the RIO kinase family found
thus far only in multicellular eukaryotes, belongs to
cytoplasmic pre-40S pre-ribosomal particles. It was
found concentrated in the cytoplasm of HeLa cells
and does not seem to shuttle between nucleus and
cytoplasm via a Crm1-dependent mechanism, at least
in the HeLa cell line used here. It sediments with 40S
ribosomal particles in a sucrose gradient and when
the small ribosomal subunit biogenesis is impaired
by depletion of either Rps15, Rps19 or RioK2, we
observed a decrease in the amount of RioK3, sug-
gesting it may well be a component of a (pre)-40S
ribosomal particle, as both mature and pre-40S
pre-ribosomal particle levels are affected by these 3
depletions. The hypothesis that RioK3 belongs to
pre-40S pre-ribosomal particles was supported by
the co-immunoprecipitation of a fraction of RioK3
with hLtv1, hEnp1 (Fig.3B) together with RioK2
which are non-ribosomal protein components of
pre-40S pre-ribosomal particles containing the 18S-E
pre-rRNA (Fig.3B, C and refs. 35, 37). Moreover,
we show that cytoplasmic 18S-E pre-rRNA is co-
precipitated with transiently expressed HA-tagged
RioK3 (Fig.4B). Altogether, these results indicate
that RioK3 is a component of one or several cyto-
plasmic pre-40S particle(s) that contain 18S-E pre-
rRNA and hLtv1, hEnp1, or RioK2, either together
in the same particle and/or present only in a subset of RioK3-
containing particles. Hence, human pre-40S particles transiently
associate with at least two RIO family proteins, RioK2 and
RioK3.
The role of RioK2 in human 40S subunit biogenesis has been
investigated in depth.
38 It was demonstrated to be involved in a
step that was described for the first time in human cells, the
cytoplasmic maturation of the ultimate 18S rRNA precursor
named 18S-E, which features a 20–30 nt extension downstream
from the 3' end of the 18S rRNA sequence (Fig.S1). In the
absence of RioK2, the 18S-E intermediate accumulates in the
cytoplasm, a phenotype that is similar to the accumulation of
the 20S pre-rRNA observed in yeast cells depleted of the Rio2p
protein. RioK2 was also recently demonstrated to be involved in
the export of pre-40S particles as well as in the recycling into the
nucleus of pre-40S particle components such as hEnp1/bystin,
Figure4. Immunoprecipitation of HA-RioK3. Fractions containing pre-40S and 40S
particles, checked for their content in HA-RioK3 by western blot, were subjected to
immunoprecipitation with an anti-HA affinity matrix. (A) western blot analysis
of the efficiency of HA-RioK3 immunoprecipitation. Proteins were extracted from
the agarose beads devoid (B0) or coated with anti-HA antibody (BHA) or from 1/2
of the input 40S fractions (Input) and subjected to western blot analysis. (B) Total RNAs
extracted from the IP fractions (B0 and BHA) or from 1/5 of the input 40S fraction
(Input) were reverse-transcribed as described in the Materials and Methods section,
and 1/100 dilutions of the corresponding cDNAs were analyzed by real-time RT-q-PCR
for the presence of 18S-E pre-rRNA, 18S and 28S rRNA and Gapdh mRNA. Quantities
of each amplicon, expressed as arbitrary units, were obtained from standard curves
determined for each RNA species as described in the Materials and Methods section.
Values presented are the means of quadruplate experiments (+/2SEM). Pair-wise
statistical analysis for (BHA) vs. (B0) was performed with Student’s t-test ***p , 0.001.
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hDim2, hLtv1 and hNob1.
35 Until recently, no role in ribosome
biogenesis was reported for the third human RIO family protein,
RioK1. In our hands, depletion of RioK1 by RNA interference in
HeLa cells did not lead to any obvious pre-rRNA maturation
defect (unpublished data). However, RioK1 may play at least an
indirect role in ribosome production since it was very recently
proposed to be an adaptor recruiting nucleolin, an RNA-binding
protein involved in ribosome synthesis, to the PRMT5 complex
for its symmetrical arginine methylation.
48 Concerning RioK3,
our results suggest that it only plays a subtle role in 40S subunit
biogenesis, although we cannot formally exclude the possibility
that the low levels of RioK3 remaining following depletion are
sufficient to support some of its functions. Nevertheless, while
RioK3 depletion did not affect the steady-state accumulation of
mature 18S rRNA and 40S ribosomal subunits, it led to a specific
increase in the levels of the 21S pre-rRNA, the levels of the other
18S rRNA precursors remaining unaffected. The accumulation
of this 21S intermediate may be caused by a delay in the
nucleoplasmic cleavage at site E in ITS1 (see Fig. S1). Since our
results suggest that RioK3 is concentrated in the cytoplasm, the
delayed processing of the 21S pre-rRNA may be the indirect
consequence of reduced recycling of some cytoplasmic pre-40S
particle components back into the nucleus, which for example
occurs in cells depleted of RioK2 (see above). Nevertheless, we
cannot totally exclude that RioK3 is present at very low level in
the nucleus at steady-state and that its function in 21S processing
is more direct.
When the biogenesis of the large ribosomal subunit is impaired
(by depletion of Rpl11 or Rpl5), we observed a spectacular and
specific increase in the steady-state levels of RioK3, which still
exclusively sediments on sucrose gradients in the 40S fraction.
Under these conditions, more RioK3 was co-immunoprecipitated
Figure5. Impact of RioK3 depletion on ribosome biogenesis. (A) Analysis of rRNA and pre-rRNA levels in HeLa cells transfected with scramble or RioK3,
Rpl11, Rps15, or Rps19 siRNAs. Identical amounts of RNAs (3 mg) from HeLa cells, extracted 48 h after transfection, were separated on a 1.2% agarose gel
and then transferred to a Hybond N+ membrane. The mature rRNA species were revealed by ethidium bromide staining and the pre-rRNA species
by hybridization with a
32P-labeled 59-ITS1 probe. Mature rRNA, 21S and 18S-E pre-rRNA species were quantified. Pre-rRNA species are described in
Fig. S1. (B) Levels of pre-rRNA intermediates in RioK3 siRNA-treated cells 48 h post transfection relative to those in cells treated with scramble siRNAs
(arbitrarily set to 1). The means (+/2 SEM) of 3 independent Northern experiments are presented. Pair-wise statistical analysis was performed with
Student’s t-test: *p , 0.05; **p , 0.01; ***p , 0.001.
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together with hLtv1 (Fig. S2), suggesting that more pre-40S
particles containing hLtv1 contain also RioK3. Moreover, 18S-E
pre-rRNA was clearly and specifically co-precipitated (Fig. S2)
Nevertheless, most of the RioK3 molecules present in the 40S
fraction were not precipitated with anti-hLtv1 antibodies and
may belong to late pre-40S particles in which hLtv1 (and hEnp1)
are no longer present or RioK3 molecules are dissociated from
the pre-40S particles during immunoprecipitation. The unexpec-
ted increase in RioK3 steady-state levels following Rpl11 or Rpl5
depletion may be due to a specific increase in the steady-state
levels of RioK3 mRNA, and/or increased translation of this
mRNA and/or stabilization of the protein. An increase in RioK3
mRNA levels is not the sole explanation, as in the absence of
Rpl11, not only RioK3 but also RioK2 and hLtv1 mRNA levels
were increased relative to Gapdh mRNA to the same moderate
extent (Fig. S3). Another possibility is that RioK3 is rapidly
turned over when not associated with cytoplasmic pre-40S
particles; in such a scenario, its steady-state levels are expected
to increase when those of cytoplasmic pre-40S particles rise, as is
the case in cells depleted of Rpl11 which display a strong increase
in 18S-E pre-rRNA amounts (Fig.5A).
Interestingly, it has recently been reported that the RIOK3
gene is overexpressed in pancreal ductal adenocarcinoma (PDAC),
one of the most lethal cancers, and that knock-down of RIOK3
expression by shRNAs in PDAC cells reduces their ability to
proliferate.
49,50 It was also recently demonstrated that RIOK3
is upregulated in erythroblasts during terminal erythroid differen-
tiation by downregulation of the microRNA miR-191
51 and that
depletion of RIOK3 mRNAs led to impaired chromatin condensa-
tion and enucleation during terminal erythroid differentiation. It
remains to be established whether these effects of RioK3 depletion
on PDAC cell proliferation and terminal erythroid differentiation
are due to impaired ribosome biogenesis and/or inhibition of
another process in which RioK3 is implicated. While this work was
under revision, Widmann and collaborators
52 published that RioK1
and RioK 3 are associated with pre-40S pre-ribosomal particles and
that depletion of RioK1affects the productionof18S rRNAandthe
recycling of several trans-acting factors.
Materials and Methods
Cell culture, plasmids and media. HeLa and U2OS cells were
grown in Dulbecco Modified Eagle Medium (DMEM) supple-
mented with 10% fetal calf serum (Gibco), 1 mM sodium
pyruvate, 100 U/mL penicillin and 100 mg/mL streptomycin
(Gibco) at 37°C with 5% CO2. LMB was purchased from LC
Laboratories and used at 10 nM or 20 nM for 2 h. Plasmids
pEGFP-RIOK3 and E46-HA-RIOK3 were constructed as
follows: the RIOK3 coding sequence was amplified by PCR
using an IMAGE clone containing the full length RIOK3
cDNA inserted in pCMVsport6-RIOK3 (clone BC039729 from
Open Biosystems) and the primers K3(6)/K3(2) and K3(6)/
K3(8), respectively (see TableS1). The DNA fragments ampli-
fied with the K3(6)/K3(2) and K3(6)/K3(8) primer pairs were
respectively cloned in frame with the sequence encoding EGFP
in plasmid pEGFP-C2 (Bioscience Clontech) using KpnI and
BamHI restriction sites and with the sequence encoding the HA
oligopeptide in plasmid E046 (a gift of D. Trouche) using KpnI
and XbaI restriction sites. pEGFP-RI0K2 described in reference
38 was kindly provided by Pierre-Emmanuel Gleizes.
Transfection of HeLa cells, protein analysis by western blot.
Exponentially growing adherent HeLa cells were transformed
with plasmid DNAs by the “Calcium phosphate” method
53 or
with jetPRIME (Polyplus) according to the manufacturer’s
recommendations. Transfected cells were grown for 24 or 48 h.
Cells were collected following trypsin digestion (Invitrogen),
washed 1 time in 5 mL Net2 buffer (50 mM Tris-HCl pH 7.4,
250 mM NaCl) containing a protease inhibitor cocktail
(complete-EDTA free, Roche), pellets were resuspended in
400 mL Net2 buffer and subjected to sonication for 5 min
(medium state, 30 sec ON, 30 sec Off; Bioruptor Diagenode).
Extracts were recovered after a 10 min centrifugation at
13 000 rpm, 4°C. Protein concentrations were determined using
the BioRad protein assay method. Samples corresponding to
40 mg of proteins were treated as described in the NuPAGE
protocol (Invitrogen) and loaded on 8% pre-cast polyacrylamide-
sodium dodecyl sulfate (SDS) gels (NuPAGE Novex Bis Tris
midi gels, Invitrogen), and after migration, transferred to nitro-
cellulose membranes using an iBlot dry blotting system (Invitro-
gen). RioK3 and RioK2 were detected with mouse monoclonal
anti-RioK3 (H00008780-MO1, Abnova) and mouse polyclonal
anti-RioK2 antibodies (H00055781-B01P Abnova) diluted at
1:1000 and 1:500 respectively in PBST buffer (137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 0.1% Tween
20) containing 5% (w/v) milk. HA oligopeptide was detected
with a 1/1000 dilution of a horseradish-peroxidase (HRP)-
conjugated mouse monoclonal anti-HA-antibody (clone 3F10,
Roche). Actin was detected with a 1/10000 dilution of a mouse
monoclonal anti-actin antibody (Millipore). hLtv1 and hEnp1
were respectively detected with rabbit polyclonal anti-hLtv1
(diluted at 1:5000) and anti-hEnp1 (diluted at 1:1000) antibobies
kindly provided by Marlène Faubladier (LBME-CNRS,
Toulouse). Rps19 was detected with a rabbit polyclonal anti-
Rps19 antibody diluted at 1:1000. For protein detection,
membranes were saturated by a 1 h incubation with PBST buffer
containing 5% milk followed by a 1 h-15 h incubation with the
primary antibodies, followed by three washing steps in PBST
buffer, and a 1 h incubation with the relevant HRP-conjugated
secondary antibodies (anti-mouse or anti-rabbit, Promega) diluted
to 1:10000 in PBST buffer containing 5% milk, and finally
washed three times for 10 min with PBST buffer. Detections were
achieved by using either regular enhanced chemoluminescence
(ECL) western blotting detection reagents (GE Healthcare) or a
more sensitive Lumilight plus (Roche) western blotting detection
kit. Chemoluminescence signals were analyzed with a BioImager
(FujiFilm, LAS 4000) and quantified with the MultiGauge
software.
Immunofluorescence microscopy. HeLa cells growing expo-
nentially on microscope cover glasses in 6-well plates were
transformed with pEGFP-RIOK3 or pEGFP-RIOK2 by the Ca-
Phosphate method. After 48 h, cover glasses were washed twice in
PBS and cells were fixed for 30 min with 4% paraformaldehyde
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in PBS. Fixed cells were washed twice with PBS. DNA was
counterstained with Hoechst 33342 (Molecular Probes) for
10 min at room temperature. The coverslips were then rinsed
twice in PBS and mounted in Mowiol 4.88 (Polyscience Inc.,
Eppelheim, Germany). Images were captured by laser-scanning
confocal microscopy (Leica SP2) using the Metavue software.
Knockdown of gene expression by RNA interference (RNAi).
The siRNA duplexes (Table S1) and siRNA-negative control
duplex (scramble siRNA) were purchased from Eurogentec.
Transfection of HeLa cells with siRNAs (10 to 50 nM) was
performed using Interferin (PolyPlus) according to the manu-
facturer’s recommendations. Control samples were transfected
with a scramble siRNA (siRNA-negative control duplex; Euro-
gentec). The efficiency of the downregulation induced by each
siRNA was assessed by a quantitative western blot analysis taking
actin as an internal control to normalize expression of the target
genes.
Cell fractionation. Cells were washed successively with
DMEM, PBS and incubated 10 min on ice in buffer A
(10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl).
Mechanical disruption was performed with a Dounce homogen-
izer in Buffer A containing 0.5 mM DTT. After centrifugation
at 1000 g for 10 min at 4°C, the supernatant, considered the
cytoplasmic fraction, was collected and the pellet, containing the
nuclei, was washed with 10 mM Tris, pH 7.5, 33 mM MgCl2,
250 mM sucrose. The nuclear fraction was resuspended in
10 mM MgCl2, 250 mM sucrose and further purified by
centrifugation for 10 min at 500 g on a sucrose cushion (0.5 mM
MgCl2, 350 mM sucrose). The nuclei were then lysed in 50 mM
Na acetate, pH 5.1, 140 mM NaCl, 0.3% SDS. Aliquots of
each fraction were analyzed by western blot after SDS-PAGE
electrophoresis (NuPAGE Novex Bis Tris midi gels, Invitrogen)
using anti-RioK3 antibody as described above and rabbit
polyclonal anti-dyskerin antibody
54 at 1:1000 dilution.
Total RNA extractions and northern hybridizations. Total
RNA extractions were performed using Trizol (Invitrogen)
according to the manufacturer’s protocol. Total RNAs (~4 mg/
well) or half of the RNA samples purified from 250 mL of the
sucrose gradient fractions were mixed with 3 volumes of loading
dye (DMSO 60% (v/v), deionised Glyoxal (Sigma) 20% (v/v),
Glycerol 5% (v/v), ethidium bromide 0.2 mg/mL in BPTE buffer
(PIPES 10 mM, Bis-TRIS 30 mM, EDTA 1 mM pH8), and
incubated 1 h at 55°C. Electrophoresis of glyoxylated RNAs in
1.2% agarose gels was performed as reported (Sambrook and
Russel, 2001), and RNAs were transferred to Amersham Hybond
N+ membranes (GE Healthcare). Mature rRNAs were analyzed
by ethidium bromide staining using a Gel-doc (BioRad), and pre-
rRNA precursors by Northern hybridization of the membranes
with a
32P-labeled ITS1 oligodeoxynucleotide probe (TableS1)
using the Rapid Hyb Buffer protocol (GE Healthcare).
Cell extract preparation and sucrose gradient sedimentation
experiments. Cells growing exponentially (1  10
8 cells per
gradient) were treated for 10 min with 50 mg/mL cycloheximide
(Sigma) directly added in the culture medium, then collected
following trypsin digestion, washed with PBS buffer supplemen-
ted with cycloheximide, and harvested by centrifugation at 500 g
for 5 min at 4°C. The dry pellet was resuspended in 1 volume of
lysis buffer (50 mM Tris-HCl, pH 7.4, 50 mM KCl, 10 mM
MgAc, 50 mg/mL cycloheximide) supplemented with 1  com-
plete EDTA-free protease inhibitor cocktail (Roche), 1 mM
dithiothreitol and 0.1 unit/mL RNasin (Promega). About 200 mL
of ice-cold glass beads were added to 1 mL of cell suspension.
Cells were broken by vigorous vortexing at 4°C, (3  1 min
separated by 1 min pauses). Lysis of cells was checked by optical
microscopy. After a first centrifugation for 10 min at 3000 rpm
to eliminate the glass beads, the supernatant or extract was
clarified by centrifugation for 10 min at 13000 rpm at 4°C.
Protein concentrations were determined using the BioRad pro-
tein assay method. The equivalent of 2 mg of proteins in 500 mL
of sample was layered on a 15–50% (w/v) sucrose gradient
prepared in sucrose buffer (50 mM TRIS-acetate, pH 7.5, 50 mM
NH4Cl, 12 mM Mg acetate, 1 mM dithiothreitol) with a
Gradient Master Former (Biocomp Instruments) and centrifuged
in polyallomer centrifuge tubes (14  89 mm, Beckman) for 15 h
at 33000 rpm and 4°C in an Optima L-100XP ultracentrifuge
(Beckman Coulter) using the SW41 rotor. Following centrifu-
gation, 18 fractions of 500 mL each were collected from the top
of the gradient with a Foxy Jr gradient fraction collector
(Teledyne ISCO). Absorbance at 254 nm was recorded during
collection with a UA-6 device (Teledyne ISCO). For protein
analysis by western blot, 250 mL of each fraction were precipit-
ated with trichloroacetic acid (final concentration 15% v/v),
washed with cold acetone, dried at room temperature and
resuspended with 30 mL loading buffer. Protein samples were
treated according to the NuPAGE protocol (Invitrogen), loaded
on SDS-PAGE and analyzed by western blot as described above.
For RNA analysis, 150 mL of gradient fractions were extracted
using GTC mix (250 mL of 4 M guanidinium isothiocyanate mix
in 10 mM TRIS-HCl (pH 8.0), 1 mM EDTA), 2 mL of glycogen
(20 mg/mL), 150 mL of 100 mM NaAc (pH 5), 225 mL of phenol
and 225 mL of chloroform. The samples were thoroughly mixed,
incubated 5 min at 65°C, centrifuged 5 min at 16000 g at 4°C.
350 mL of the aqueous phase were then precipitated with 2 vol
ethanol, centrifuged, dried, dissolved in 10 mL nuclease-free water
and analyzed by northern blot.
Preparative 15–50% (w/v) sucrose gradients were poured/
freezed in 4 successive layers (50%, 40%, 30%, 15% sucrose,
9 mL each) in polyallomer centrifuge tubes (25  89 mm, 38 mL,
Beckman). An amount of commercial Hela cytoplasmic extract
(CILbiotech; B-7000 Mons) corresponding to 25 mg of proteins
was loaded on a defrosted sucrose gradient and tubes were
centrifuged at 4°C at 32000 rpm for 16 h in a SW32 rotor in an
Optima L-100XP ultracentrifuge (Beckman Coulter).
Immunoprecipitations and RT-q-PCR experiments. Immuno-
precipitations of hLtv1 and hEnp1 were performed using
aliquots of 40S fractions prepared from commercial HeLa
cytoplasmic extracts. Anti-hLtv1 and hEnp1 coated beads were
prepared as follows: for each IP, 50 mL of proteinA-Sepharose
beads (GE Healthcare) equilibrated in sucrose buffer (50 mM
Tris-acetate, pH 7.5, 50 mM NH4Cl, 12 mM Mg acetate, 1
mM dithiothreitol) supplemented with 1  complete EDTA-
free protease inhibitor cocktail (Roche) and 0.1 U/ mL RNasin
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(Promega) were incubated with 20 mL of anti-hLtv1, anti-hEnp1
or non-immune serum in a total volume of 500 mL of sucrose
buffer, during 1 h at 4°C on a rotating wheel. After a 2 min
centrifugation (10000 rpm) to eliminate the flow-through,
followed by 4 washes of the beads using 1 mL of ice-cold
sucrose buffer, the beads were incubated with 400 mL of pooled
40S fractions in a total volume of 1.2 mL sucrose buffer, at 4°C
during 1 h on a rotating wheel. After elimination of the flow
through, bead pellets were washed 5 times with 1 mL of ice-cold
sucrose buffer, and during the last washing step, bead suspen-
sions were divided into two halves and treated for protein and
RNA analysis as described for the HA-RioK3 IP.
To immunoprecipitate HA-RioK3, a cytoplasmic extract
prepared from transiently transfected cells as described above
corresponding to about 4 mg of protein was subjected to
ultracentrifugation in sucrose gradient, and the fractions contain-
ing pre-40S and 40S particles, checked for their content in HA-
RioK3, were pooled. Aliquots corresponding to 1/3 of the 40S
pool were incubated by rotation on a wheel for 1 h at 4°C with
100 mL (bead volume) of either control agarose resin (Pierce) (B0)
or anti-HA affinity Matrix (Roche) (BHA) in a total volume of
1.5 mL. Beads were pre-equilibrated and the incubation volume
adjusted with IP 200 buffer (20 mM TRIS-HCl pH 7.5,
200 mM NaCl, 5 mM Mg acetate, 1 mM dithiothreitol, 0.1%
Triton X100) supplemented with 1  complete EDTA-free
protease inhibitor cocktail (Roche) and [0.1 U/ mL RNasin
(Promega)]. Flow-through were collected after 1 min 30 sec
centrifugation at 10 000 rpm, and the bead pellets were washed
6 times with 1 mL of ice-cold IP 200 buffer. During the last
washing, bead suspensions were divided into two aliquots: a
200 ml aliquot for protein analysis and a 800 ml aliquot trans-
ferred to a new tube for RNA analysis. After a last centrifugation
step, the remaining buffer was carefully discarded from the
aliquot for protein analysis and the 20 mL dried beads were
directly resuspended in 30 mL of NuPAGE lithium dodecyl
sulfate sample buffer supplemented with NuPAGE sample-
reducing agent (Invitrogen), heated 10 min at 70°C, and 15 ml
loaded on NuPAGE Novex 8% Bis-Tris gels (Invitrogen),
together with an aliquot corresponding to J of the Input ana-
lyzed after treatment by the beads, and transferred to nitro-
cellulose membranes for western blot analysis. The aliquot for
RNA analysis was treated as follows. Bead pellets (80 mL) were
resuspended in 150 mL of IP 200 buffer and extracted using
the GTC mix as described above for gradient fractions. RNA
pellets were resuspended in 40 mLH 2O and treated with 1 mL
DNase (Promega) for 1 h at 37°C. Reaction was stopped with
5 mL of stop DNase buffer and 50 mL of saturated phenol
(pH 4.5). The mixture was vigorously shaken and centrifuged
5 min at 13000 rpm and at 4°C. 45 mL of aqueous phase were
kept on ice. The phenolic phase was washed using 50 mLH 2O
and this second aqueous phase was pooled with the first one.
This combined aqueous phase was extracted using 90 mLo f
chloroform and 85 mL of aqueous phase were precipitated with
500 mL ethanol, 9 mL 3 M sodium acetate and 2 mL glycogen at
20 mg/mL. After 5 min centrifugation at 13000 rpm, 4°C, the
RNA pellets were air-dried and resuspended in 10 mL of nuclease-
free water. An aliquot of the input 40S fraction corresponding to
1/5 of the amount immunoprecipitated on beads was DNase-
treated in parallel. Half of the aliquots of the DNase-treated
RNAs were reverse transcribed using the Superscript II reverse
transcriptase (Invitrogen) and random primers following the
protocol provided by the enzyme’s manufacturer. Following
cDNA synthesis, RNAs were hydrolyzed for 15 min at 70°C in
the presence of 115 mM NaOH. Samples were neutralized with
115 mM HCl and the cDNAs were analyzed by RT-q-PCR on
a Mastercycler ep realplex (Eppendorf). Each RT-q-PCR reac-
tion was performed in triplicate or quadruplate in 15 ml final
volume containing 7.5 ml of the iQ SYBR Green Supermix
(Bio-Rad), 0.5 mM of each specific oligo and 5 ml of a 1/100
dilution of the cDNA samples obtained from reverse transcrip-
tion of the Input, B0 and BHA RNA aliquots. The cycle
parameters were: 10 min at 95°C as pre-amplification step, 15 sec
at 95°C–15 sec at 55°C–30 sec at 68°C for 40 cycles as
amplification steps, and warming from 60°C to 95°C for the
melting curve. Specificity for each RT-PCR reaction was con-
firmed by the observation of only one melting peak between 80–
90°C depending on the length of the amplified fragment. The
levels of each cDNA, expressed in arbitrary units, were calculated
from standard curves fitted to a logarithmic function, obtained
from 6 different appropriate serial dilutions of the cDNAs
synthesized from total RNAs purified from the starting HeLa
cytoplasmic extract. Efficiencies calculated from these curves
ranged between 53 and 72%. The primers used for RT-q-PCR are
indicated in Table S1.
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